Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 400

1.
2.

Use and outcomes of adjuvant chemotherapy in older women with breast cancer.

Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Goodwin JS.

J Clin Oncol. 2006 Jun 20;24(18):2750-6.

PMID:
16782915
3.
4.

Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.

Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI.

Cancer. 2005 Jun 1;103(11):2241-51.

5.
6.
7.

Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.

Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI.

Breast Cancer Res Treat. 2006 Oct;99(3):313-21. Epub 2006 Apr 1.

PMID:
16583264
8.
9.

Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.

Johansson P, Fohlin H, Arnesson LG, Dufmats M, Nordenskjöld K, Nordenskjöld B, Stål O; South-East Sweden Breast Cancer Study Group.

Acta Oncol. 2009;48(4):504-13. doi: 10.1080/02841860902718754.

PMID:
19235568
10.

Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy.

Baxter NN, Durham SB, Phillips KA, Habermann EB, Virning BA.

J Am Geriatr Soc. 2009 Mar;57(3):403-11. doi: 10.1111/j.1532-5415.2008.02130.x.

PMID:
19278395
11.

A population-based study on variations in the use of adjuvant systemic therapy on postmenopausal patients with early stage breast cancer.

Nagel G, Röhrig B, Hoyer H, Wedding U, Katenkamp D.

J Cancer Res Clin Oncol. 2003 Mar;129(3):183-91. Epub 2003 Apr 23.

PMID:
12709795
12.

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.

Hershman D, Hall MJ, Wang X, Jacobson JS, McBride R, Grann VR, Neugut AI.

Cancer. 2006 Dec 1;107(11):2581-8.

13.

T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy.

Kaplan HG, Malmgren JA, Atwood M.

Breast J. 2009 Sep-Oct;15(5):454-60. doi: 10.1111/j.1524-4741.2009.00789.x. Epub 2009 Aug 4.

PMID:
19671105
14.

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR.

J Natl Cancer Inst. 2007 Feb 7;99(3):196-205.

PMID:
17284714
15.

Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.

Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R.

J Clin Oncol. 2006 Feb 20;24(6):872-7.

PMID:
16484696
17.

Effectiveness of radiation therapy for older women with early breast cancer.

Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG.

J Natl Cancer Inst. 2006 May 17;98(10):681-90.

PMID:
16705122
18.

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

BMC Cancer. 2007 Apr 12;7:63.

19.

Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.

Doyle JJ, Neugut AI, Jacobson JS, Grann VR, Hershman DL.

J Clin Oncol. 2005 Dec 1;23(34):8597-605.

PMID:
16314622
20.

Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer.

Sail KR, Franzini L, Lairson DR, Du XL.

Value Health. 2012 Jan;15(1):72-80. doi: 10.1016/j.jval.2011.10.004.

Supplemental Content

Support Center